Impaired coronary microvascular and left ventricular diastolic functions in patients with ankylosing spondylitis

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 306-312

  Caliskan, Mustafa ^a   Erdogan, Dogan ^a   Gullu, Hakan ^a   Yilmaz, Sema ^a   Gursoy, Yusuf ^a   Yildirir, Aylin ^a   Yucel, Eftal ^a   Muderrisoglu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Coronary flow reserve; Diastolic function; Echocardiography

Indexed keywords

C REACTIVE PROTEIN; DIPYRIDAMOLE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; ELECTROCARDIOGRAM; FEMALE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FILLING; HUMAN; MALE; MICROANGIOPATHY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CASE-CONTROL STUDIES; CORONARY CIRCULATION; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 38049082059     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.003     Document Type: Article

References (30)

1. Lautermann D., and Braun J. Ankylosing spondylitis-cardiac manifestations. Clin Exp Rheumatol 20 (2002) S11-S15
2. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 52 (1993) 174-176
3. Asanuma Y., Oeser A., Shintani A.K., et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349 (2003) 2407-2415
4. Chung C.P., Oeser A., Raggi P., et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 52 (2005) 3045-3053
5. Divecha H., Sattar N., Rumley A., et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109 (2005) 171-176
6. Galderisi M., Cicala S., Caso P., et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90 (2002) 860-864
7. Erdogan D., Gullu H., Caliskan M., et al. Coronary flow reserve in dipper and non-dipper hypertensive patients. Blood Pressure 14 (2005) 345-352
8. Hamouda M.S., Kassem H.K., Salama M., et al. Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal Doppler echocardiography. Am J Cardiol 86 (2000) 305-308
9. Britten M.B., Zeiher A.M., and Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coronary Artery Dis 15 (2004) 259-264
10. Mosseri M., Yarom R., Gotsman M.S., and Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 5 (1986) 964-972
11. Saraste M., Koskenvuo J., Knuuti J., Toikka J., Laine H., Niemi P., Sakuma H., and Hartiala J. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 21 (2001) 114-122
12. Caiati C., Montaldo C., Zedda N., Bina A., and Iliceto S. New noninvasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 99 (1999) 771-778
13. van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27 (1984) 361-368
14. Erdogan D, Gullu H, Caliskan M, et al. The influence of circadian blood pressure changes on aortic distensibility and left ventricular diastolic function in hypertensive individuals. Int J Cardiovasc Imaging 2005;1-9 [Epub ahead of print].
15. Erdogan D., Gullu H., Caliskan M., et al. Coronary flow reserve and coronary microvascular functions are strongly related to serum uric acid concentrations in healthy adults. Coronary Artery Dis 17 (2006) 7-14
16. Voci P., Pizzuto F., Mariano E., et al. Measurement of coronary flow reserve in the anterior and posterior descending coronary arteries by transthoracic Doppler ultrasound. Am J Cardiol 90 (2002) 988-991
17. Caiati C., Zedda N., Montaldo C., Montischi R., and Iliceto S. Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine: a non-invasive, rapid and effective method for coronary flow reserve assessment. J Am Coll Cardiol 34 (1999) 122-130
18. Lambertz H., Tries H.P., Stein T., and Lethen H. Non-invasive assessment of coronary flow reserve with transthoracic signal-enhanced Doppler echocardiography. J Am Soc Echocardiogr 12 (1999) 186-195
19. Wikstrom J., Gronros J., Bergstrom G., and Gan L.M. Functional and morphologic imaging of coronary atherosclerosis in living mice using high-resolution color Doppler echocardiography and ultrasound biomicroscopy. J Am Coll Cardiol 46 (2005) 720-727
20. De Bruyne B., Hersbach F., Pijls N.H., et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation 104 (2001) 2401-2406
21. Wang L., Jerosch-Herold M., Jacobs Jr. D.R., Shahar E., and Folsom A.R. Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 47 (2006) 565-572
22. Park CS, Youn HJ, Kim JH, et al. Relation between peripheral vascular endothelial function and coronary flow reserve in patients with chest pain and normal coronary angiogram. Int J Cardiol 2005 [Epub ahead of print].
23. Braun J., Bollow M., Remlinger G., et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41 (1998) 58-67
24. Divecha H., Sattar N., Rumley A., et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 109 (2005) 171-176
25. Sari I., Okan T., Akar S., et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45 (2006) 283-286
26. Yildirir A., Aksoyek S., Calguneri M., Oto A., and Kes S. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin Rheumatol 21 (2002) 129-134
27. Crowley J.J., Donnelly S.M., Tobin M., et al. Doppler echocardiographic evidence of left ventricular diastolic dysfunction in ankylosing spondylitis. Am J Cardiol 71 (1993) 1337-1340
28. Gould B.A., Turner J., Keeling D.H., Hickling P., and Marshall A.J. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 51 (1992) 227-232
29. Wilson R.F., Laughlin D.E., Ackell P.H., et al. Transluminal subselective measurement of coronary blood flow velocity and vasodilator reserve in man. Circulation 72 (1985) 82-92
30. Galderisi M., Cicala S., D'Errico A., de Divitiis O., and de Simone G. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens 22 (2004) 2201-2208